LIVE FROM SEC EDGAR
Every SEC filing that moves stocks, the minute it lands.
Earnings, insider buys and sells, 5% stakes, IPO filings and red flags, summarized in plain English.
8-KInsider
5% stakeIPORed flag
center = newest
Filings per hour last 24 hours
Entera Bio Ltd.ENTX · Nov 6, 4:15 PM ET
Entera Bio reports Q3 2026 results; Phase 3 EB613 site activation expected late 2026
Entera Bio reported a Q3 2026 net loss of $15.6 million and said cash resources are expected to fund the planned EB613 Phase 3 program through topline results and an NDA submission.
AI-generated summary, checked against the filing. Can contain errors: read the original filing ↗. Not investment advice.